Shire and tiny Lexington biotech say hemophilia drug trial misses mark – Boston Business Journal


Boston Business Journal
Shire and tiny Lexington biotech say hemophilia drug trial misses mark
Boston Business Journal
Shares of Xenetic Biosciences sank on Monday after the Lexington biotech announced a significant setback in its collaboration with Shire plc on a hemophilia drug. Xenetic (Nasdaq: XBIO), which has seven employees, announced disappointing results from a ...

and more »

Read More

Puma Biotech Shares Are Roaring On An FDA Review. Here’s What Could Still Go Wrong – Forbes


Forbes
Puma Biotech Shares Are Roaring On An FDA Review. Here's What Could Still Go Wrong
Forbes
The story of Puma Biotechnology has been one of the most dramatic in the drug business. Three years ago Puma's chief executive, Alan Auerbach, was a billionaire based on his holdings in the company. But now the company's shares are down 80% from ...
Puma Biotech Surges To 6-Month High On Likely Cancer Drug ApprovalInvestor's Business Daily
Puma Biotech stock surges 50% on favorable FDA release for breast cancer drugMarketWatch
Here's Why Wednesday Is The Next Big Catalyst For Puma BiotechBenzinga
Reuters -Motley Fool -StreetInsider.com
all 165 news articles »

Read More

Puma Biotech Shares Are Roaring On An FDA Review. Here’s What Could Still Go Wrong – Forbes


Forbes
Puma Biotech Shares Are Roaring On An FDA Review. Here's What Could Still Go Wrong
Forbes
The story of Puma Biotechnology has been one of the most dramatic in the drug business. Three years ago Puma's chief executive, Alan Auerbach, was a billionaire based on his holdings in the company. But now the company's shares are down 80% from ...
Puma Biotech Surges To 6-Month High On Likely Cancer Drug ApprovalInvestor's Business Daily
Puma Biotech stock surges 50% on favorable FDA release for breast cancer drugMarketWatch
Puma Biotech Makes Big Breakthrough In Breast Cancer TreatmentBenzinga
Reuters -StreetInsider.com
all 121 news articles »

Read More

Biotech Movers: Radius Health, Amgen, Paratek – TheStreet.com


TheStreet.com
Biotech Movers: Radius Health, Amgen, Paratek
TheStreet.com
JUST UPDATED – TheStreet's Biotech Bible! Before you invest one single dime in any biotech stock you have got to KNOW WHAT YOU ARE BUYING! Get THE most comprehensive text covering the 186 biotech companies that have gone public since 2013!
Amgen And UCB Announce TopLine Phase 3 Data From ActiveComparator Study Of EVENITY Romosozumab In ...Amgen

all 97 news articles »

Read More